KR860001393B1 - Process for the preparation of 1-alkyl-2-oxo-4-acyl-1,2,3,4-tetrahydropyrazines - Google Patents
Process for the preparation of 1-alkyl-2-oxo-4-acyl-1,2,3,4-tetrahydropyrazines Download PDFInfo
- Publication number
- KR860001393B1 KR860001393B1 KR1019840005447A KR840005447A KR860001393B1 KR 860001393 B1 KR860001393 B1 KR 860001393B1 KR 1019840005447 A KR1019840005447 A KR 1019840005447A KR 840005447 A KR840005447 A KR 840005447A KR 860001393 B1 KR860001393 B1 KR 860001393B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- carbon atoms
- formula
- acid
- compound
- Prior art date
Links
- 0 *C(N1CCNCC1)=O Chemical compound *C(N1CCNCC1)=O 0.000 description 1
- XRHOCDATAMGPEO-UHFFFAOYSA-N CN(CC1)C=CN1I Chemical compound CN(CC1)C=CN1I XRHOCDATAMGPEO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 촌충 및 간, 폐흡충류에 대해 강한 구충작용을 나타내는 4-옥소-1,3,4,6,7,11b-헥사히드로-4H-피라지노[2,1-a] 이소퀴놀린 유도체의 제조에 아주 유용하게 사용될 수 있는 다음 구조식(Ⅰ)로 표시되는 1-알킬-2-옥소-4-아실-1,2,3,4-테트라히드로피라진의 새로운 제조방법에 관한 것이다.The present invention relates to 4-oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline derivatives exhibiting strong antiparasitic activity against tapeworms and liver and lung repellents. It relates to a new method for preparing 1-alkyl-2-oxo-4-acyl-1,2,3,4-tetrahydropyrazine represented by the following structural formula (I) which can be very usefully used for preparation.
구조식(Ⅰ)에서, R1은 탄소수 1-7개 까지의 저급 알킬기 또는 벤젠고리에 할로겐원자, 히드록실기, 탄소수 1-7개 까지의 저급알킬기, 탄소수 1-7개 까지의 저급 알콕시가 치환된 펜에틸 또는 벤질기이다. 또한, R2는 수소, 탄소수 1-7개의 까지의 저급 알킬기, 씨클로 알킬기, 벤젠고리에 니트로기, 히드록실기, 탄소수 1-7개 까지의 저급 알킬기 또는 알콕시기, 또는 할로겐 원자가 치환된 페닐기이다.In structural formula (I), R 1 is a halogen atom, a hydroxyl group, a lower alkyl group having 1-7 carbon atoms, or a lower alkoxy having 1-7 carbon atoms substituted in the lower alkyl group or benzene ring having 1 to 7 carbon atoms. Phenethyl or benzyl group. R 2 is hydrogen, a lower alkyl group having 1 to 7 carbon atoms, a cycloalkyl group, a nitro group, a hydroxyl group, a lower alkyl group having 1 to 7 carbon atoms or an alkoxy group, or a phenyl group substituted with a halogen atom. .
상기 구조식(Ⅰ)의 화하물을 제조하는 방법이나 구조식(Ⅰ)의 화합물로 부터 프라지콴텔을 제조하는 방법은 본 발명의 발명자들이 발명한 영국특허공보 2,126,212A(1984)와 대한민국 특허출원(83-2418)에 기술되어 있다.The method for preparing the compound of formula (I) or the method for preparing praziquantel from the compound of formula (I) is disclosed in the British Patent Publication No. 2,126,212A (1984) and the Republic of Korea Patent Application (83) -2418).
공지되었거나 출원중인 방법은 아래 구조식(Ⅱ)나 (Ⅲ)의 화합물을 산성 조건하에서 고리화하는 방법이다.Known or pending methods are those in which the compounds of formula (II) or (III) are cyclized under acidic conditions.
본 발명은 이들 방법과는 달리 신규 화합물인 구조식(Ⅳ)의 화합물을 합성하고 이 화합물을 새로운 고리화 반응에 의해서 높은 수율로 신규 화합물인 구조(Ⅴ)의 화합물을 제조한 다음 구조식(Ⅴ)의 화합물을 알킬할라이드와 반응시켜 알킬화하므로서 구조식(Ⅰ)의 화합물을 제조하는 새로운 방법이다.Unlike these methods, the present invention synthesizes a compound of formula (IV), which is a novel compound, and prepares a compound of structure (V), which is a new compound, in high yield by a new cyclization reaction. A new process for preparing compounds of formula (I) by reacting compounds with alkyl halides to alkylate them.
상기 구조식(Ⅳ)에서, R2는 구조식(Ⅰ)의 R2와 동일한 치환기를 나타내며, R3는 메틸 또는 에틸을 나타내거나, 또는 두개의 R3가 메틸렌기로 환을 이루는 씨클릭 아세탈이다. 또한, 구조식(Ⅴ)에서 R2는 구조식(Ⅰ)의 R2와 동일한 치환기를 나타낸다.In the above structural formula (Ⅳ), R 2 represents the same substituent as R 2 of formula (Ⅰ), R 3 is clicking, Mr. or represent methyl or ethyl, or both R 3 groups form a ring methylene acetal to be. Also, R 2 in the formula (Ⅴ) represents the same substituent as R 2 of formula (Ⅰ).
구조식(Ⅳ)의 화합물을 구조식(Ⅴ)의 화합물로 전환시키는 새로운 고리와 반응은 유기용매를 사용하여 촉매양의 산 존재하에서 이루어진다. 이때 사용될 수 있는 유기 용매는 탄소수 1-4개의 저급 알콜, 탄소수 1-2개의 클로로 탄화수소, 니트릴탄화수소 또는 에텔이 사용될 수 있으며, 산은 진한황산, 염산, 개미산, 메탄설폰사, 아세트산, 트리플루오로 아세트산, 보론트리플루오로 에텔부가물 또는 폴리인산이 사용될 수 있다. 반응온도와 시간은 사용하는 산 및 유기용매에 따라 0-80℃에서 1-5시간이 필요하다. 그러나 가장 바람직한 반응조건으로는 니트릴탄화수소 용매에서 진한 황산이나 염산을 사용하여 환류반응시키는 것이다.The reaction with the new ring to convert the compound of formula (IV) to the compound of formula (V) takes place in the presence of a catalytic amount of acid using an organic solvent. The organic solvent that can be used at this time may be a lower alcohol having 1-4 carbon atoms, chloro hydrocarbons having 1-2 carbon atoms, nitrile hydrocarbon or ether, the acid is concentrated sulfuric acid, hydrochloric acid, formic acid, methanesulfone, acetic acid, trifluoro acetic acid , Borontrifluoro ether adduct or polyphosphoric acid may be used. The reaction temperature and time are 1-5 hours at 0-80 ° C depending on the acid and organic solvent used. However, the most preferable reaction condition is reflux reaction using concentrated sulfuric acid or hydrochloric acid in nitrile hydrocarbon solvent.
구조식(Ⅴ)의 화합물을 알킬 할라이드로 알킬화하여 구조식(Ⅰ)의 화합물을 제조하는 반응은 DMF와 같은 극성 용매 중에서 염기 존재하에서 알킬화하는 방법과 클로로탄화수소 용매 중에서 4급 알킬 암모늄염을 상이등 촉매(Phase transfer catalyst)로 사용하여 알카리 존재하에서 알킬화하는 방법이 있다. 사용하는 알카리로는 알카리 토금속의 수산화물이나 탄산염이 사용될 수 있으며, 상이등 촉매로는 탄소수 1-4개의 알킬 4급 암모늄 클로라이드나 브로마이드 또는 벤질트리알킬 4급 암모늄 클로라이드나 브로마이드가 사용될 수 있고 반응온도는 10-80℃가 적합하다. 그러나 알킬할라이드가 클로라이드나 브로마이드인 경우 극성 요매 중에서의 알킬화 반응보다는 상이등 촉매를 사용한 방법이 온화한 반응조건에서 높은 수율로 구조식(Ⅰ)을 얻을 수 있는 장점이 있었다.The reaction for preparing the compound of formula (I) by alkylating the compound of formula (V) with an alkyl halide is performed by alkylation in the presence of a base in a polar solvent such as DMF and a quaternary alkyl ammonium salt in a chlorohydrocarbon solvent. There is a method of alkylation in the presence of alkali using a transfer catalyst). Alkaline may be used as alkali earth metal hydroxides or carbonates, and different catalysts may be alkyl quaternary ammonium chloride or bromide or benzyltrialkyl quaternary ammonium chloride or bromide of 1-4 carbon atoms, the reaction temperature is 10-80 ° C is suitable. However, when the alkyl halide is chloride or bromide, the method using a catalyst other than the alkylation reaction in the polar solvent has the advantage of obtaining the structural formula (I) in high yield under mild reaction conditions.
출발물질인 구조식(Ⅳ)는 그리신(glycine)을 아실화한 아실그리신을 구조식(Ⅵ)의 활성 무수물로 전환시킨 다음 아미노아세트 알데히드디알킬아세탈과 반응하여 제조할 수 있다.Structural formula (IV) can be prepared by converting acylglycine, which acylates glycine, into an active anhydride of structural formula (VI), followed by reaction with aminoacetaldehyde dialkylacetal.
구조식(Ⅵ)에서 R2는 구조식(Ⅰ)에서의 R2와 같고, R4는 탄소수 1-7개 까지의 저급알킬기 또는 벤질기이다.R 2 in formula (Ⅵ) is the same as R 2 in formula (Ⅰ), R 4 is a lower alkyl group or a benzyl group having a carbon number of from 1-7.
다음의 실시예들은 본 발명의 기술적인 문제들을 자세히 설명하여 줄 것이나, 본 발명이 반드시 이에 국한되는 것은 아니다.The following examples will illustrate the technical problems of the present invention in detail, but the present invention is not necessarily limited thereto.
[실시예 1]Example 1
2,5-디옥소-3,6-디아자-8,8-디메톡시옥탄(Ⅳ;R2=R3=CH3)의 제조Preparation of 2,5-dioxo-3,6-diaza-8,8-dimethoxyoctane (IV; R 2 = R 3 = CH 3 )
3구 둥근바닥 플라스크에 트리에틸아민 29.29ml와 디클로로메탄 250ml를 넣은 후 여기에 아세틸글라이신 23.4g(0.20몰)을 녹인 다음, 무수칼슘클로라이드관을 부착시킨 후 -14℃로 유지한다. 여기에 이소부틸클로로포르메이트 27.24ml(0.21몰)을 천천히 떨어뜨리고 20분 후에 아미노아세트알데히드 디메틸아세탈 22.88ml(0.21몰)을 천천히 떨어뜨린 다음 30분 동안 환류반응시킨다. 반응액을 -5℃로 냉각시킨후 트리에틸아민의 염산염을 여과하여 제거한다. 유기층을 포화포타슘카보네이트 수용액으로 4회 씻어낸 후 용매를제거하고 에틸아세테이트로 재결정하면 29.60g(72.5%)의 상기 화합물을 얻는다.29.29 ml of triethylamine and 250 ml of dichloromethane were added to a three necked round bottom flask, and 23.4 g (0.20 mol) of acetylglycine was dissolved therein, and anhydrous calcium chloride tube was attached thereto and maintained at -14 ° C. 27.24 ml (0.21 mol) of isobutyl chloroformate was slowly dropped, and after 22 minutes, 22.88 ml (0.21 mol) of aminoacetaldehyde dimethylacetal was slowly dropped and refluxed for 30 minutes. After cooling the reaction solution to -5 ℃, hydrochloride of triethylamine is filtered off. The organic layer was washed four times with an aqueous saturated potassium carbonate solution and then the solvent was removed and recrystallized with ethyl acetate to obtain 29.60 g (72.5%) of the compound.
녹는점:107-108℃(에틸아세테이트)Melting Point: 107-108 ° C (Ethyl Acetate)
Hnmr(CDCl3):δ2.05(s, 3H, 아세틸 수소) 3.40(s, 6H, 디메톡시 수소)Hnmr (CDCl 3 ): δ 2.05 (s, 3H, acetyl hydrogen) 3.40 (s, 6H, dimethoxy hydrogen)
3.98(d, 2H, -NCH2CH,J=5,6Hz), 4.45(t, 1H, -CH t63.98 (d, 2H, -NCH 2 CH, J = 5,6 Hz), 4.45 (t, 1H, -CH t6
J=5,6Hz), 7.24(b, 2H, 아민수소)J = 5,6 Hz), 7.24 (b, 2H, amine hydrogen)
i, r. (KBr), cm-1:3280(s), 3070(m), 2940(w), 1670(w), 1650(s), 1630(s), 1550(s), 1420(w), 1370(w), 1280(w), 1240(m), 1130(m), 1070(m), 690(m)i, r. (KBr), cm -1 : 3280 (s), 3070 (m), 2940 (w), 1670 (w), 1650 (s), 1630 (s), 1550 (s), 1420 (w), 1370 ( w), 1280 (w), 1240 (m), 1130 (m), 1070 (m), 690 (m)
[실시예 2]Example 2
1-시클로헥실-2,5-디아자-1,4-디옥소-7,7-디메톡시헵탄(Ⅳ; R2=C6H11, R3=CH3)의 제조Preparation of 1-cyclohexyl-2,5-diaza-1,4-dioxo-7,7-dimethoxyheptane (IV; R 2 = C 6 H 11 , R 3 = CH 3 )
실시예 1에서와 같은 방법으로 헥사히드로히프릭산과 아미노 아세트 알데히드 디메칠 아세탈을 사용하여 70.5%의 수율로 상기의 화합물을 얻었다.The compound was obtained in the yield of 70.5% using hexahydrohydric acid and amino acetaldehyde dimethyl acetal in the same manner as in Example 1.
녹는점:112-113℃(에칠아세테이트-헥산)Melting Point: 112-113 ° C (Ethyl Acetate-hexane)
Hnmr(CDCl3):δ1.15-2.40(m, 11H, 시클로헥실 수소), 3.45(s, 6H, 디메톡시 수소)Hnmr (CDCl 3 ): δ 1.15-2.40 (m, 11H, cyclohexyl hydrogen), 3.45 (s, 6H, dimethoxy hydrogen)
3.44(s, 2H, -NHCH2CO-), 4.00(d, 2H, -NHCH2CH-, J=5.2Hz), 4.45(t, 1H, -CH t6-1 J=5.2Hz), 6.80(s, 2H, 아민수소)3.44 (s, 2H, -NHCH 2 CO-), 4.00 (d, 2H, -NHCH 2 CH-, J = 5.2 Hz), 4.45 (t, 1H, -CH t6-1 J = 5.2 Hz), 6.80 ( s, 2H, amine hydrogen)
i, r, (KBr), cm-1:3,300(s), 3,100(w), 2,950(m), 1,680(w), 1630(s), 1,570(m), 1,550(m), 1,530(w), 1,440(w), 1,130(w), 1,060(w)i, r, (KBr), cm -1 : 3,300 (s), 3,100 (w), 2,950 (m), 1,680 (w), 1630 (s), 1,570 (m), 1,550 (m), 1,530 (w ), 1,440 (w), 1,130 (w), 1,060 (w)
[실시예 3]Example 3
4-아세틸-1H-3,4-디히드로피라진-2-온(V;R2=CH3)의 제조Preparation of 4-acetyl-1H-3,4-dihydropyrazin-2-one (V; R 2 = CH 3 )
2,5-디옥소-3,6-디아자-8,8-디메톡시옥탄(Ⅳ;R2=R3=CH3) 17.41g(0.085몰)과 아세토니트릴 500ml을 1ℓ 둥근바닥 플라스크에 넣은 후 진한황산 0.5ml을 넣고 2시간 반동안 천천히 환류 반응시킨다. 냉각한 후에 무수 K2CO316g을 가루로 빻아서 용기내에 넣은 다음 2-3시간 잘 교반한 후 여과하여 고형물을 버리고 용액을 농축하여 상기 화합물 8.03g(67.2%)의 결정을 얻었다.17.41 g (0.085 mol) of 2,5-dioxo-3,6-diaza-8,8-dimethoxyoctane (IV; R 2 = R 3 = CH 3 ) and 500 ml of acetonitrile were placed in a 1 l round bottom flask. After adding 0.5 ml of concentrated sulfuric acid, the reaction was slowly refluxed for 2 and a half hours. After cooling, 16 g of anhydrous K 2 CO 3 was ground into a powder, put into a container, stirred well for 2-3 hours, filtered, the solids were discarded, and the solution was concentrated to give 8.03 g (67.2%) of crystals.
녹는점:150-151℃(아세토니트릴)Melting Point: 150-151 ° C (acetonitrile)
Hnmr(DMSO):δ2.10, 2.13(s, 3H, 아세탈); 4.22, 4.32(s, 2H, -COCH2N-); 5.74, 5.84(d, 1H, 비닐수소, J=5.0Hz); 6.39, 6.54(d, 1H, J=5.0Hz); 9.72(b, 1H, 아민수소)Hnmr (DMSO): δ 2.10, 2.13 (s, 3H, acetal); 4.22, 4.32 (s, 2H, -COCH 2 N-); 5.74, 5.84 (d, 1H, vinyl hydrogen, J = 5.0 Hz); 6.39, 6.54 (d, 1H, J = 5.0 Hz); 9.72 (b, 1H, amine hydrogen)
i. r.(KBr),cm-1:3200(w), 3070(s), 2930(m), 1690(s), 1660(s), 1600(s), 1410(m), 1380(m), 1340(w), 1090(w), 960(w), 930(w), 810(m), 700(w)ir (KBr), cm -1 : 3200 (w), 3070 (s), 2930 (m), 1690 (s), 1660 (s), 1600 (s), 1410 (m), 1380 (m), 1340 (w), 1090 (w), 960 (w), 930 (w), 810 (m), 700 (w)
[실시예 4]Example 4
4-시클로헥실카보닐-1H-3,4-디히드로피라진-2-온(Ⅴ;R2=C6H11)의 제조Preparation of 4-cyclohexylcarbonyl-1H-3,4-dihydropyrazin-2-one (V; R 2 = C 6 H 11 )
1-시클로헥실-2,5-디아자-1,4-디옥소-7,7-디메톡시헵탄(Ⅳ;R2=C6H11, R3=CH3) 12.12g(0.0445몰)을 2ℓ 둥근 바닥플라스크에 넣고 아세토니트릴 1.5ℓ을 가한 다음 진한황산 0.8ml을 넣고 1시간동안 천천히 환류반응시킨다. 무수 K2CO35.36g을 넣은 후 2-3시간 교반한다. 여과하여 고형물을 제거하고 농축하면 상기 화합물 7.14g(77%)의 생성물을 얻는다.12.12 g (0.0445 mol) of 1-cyclohexyl-2,5-diaza-1,4-dioxo-7,7-dimethoxyheptane (IV; R 2 = C 6 H 11 , R 3 = CH 3 ) Place in a 2 l round bottom flask, add 1.5 l of acetonitrile, add 0.8 ml of concentrated sulfuric acid, and slowly reflux for 1 hour. 5.36 g of anhydrous K 2 CO 3 was added, followed by stirring for 2-3 hours. Filtration removes the solid and concentrates to yield 7.14 g (77%) of the compound.
녹는점:168.5-170.5℃(에틸아세테이트-헥산)Melting Point: 168.5-170.5 ° C (Ethyl Acetate-hexane)
Hnmr(CDCl3):δ1.0-2.1(b,10H, 시클로헥실수소), 2.2-2.9(b, 1H, 시클로헥실 카보닐 α-수소), 4.38(s, 2H, -COCH2N-), 5.80(dd, 1H, 비닐 J1-6=5.0Hz, J5-6=5.8Hz), 6.30(d, 1H, 비닐 J5-6=5.8), 9.15(b, 1H, 아민의 수소)Hnmr (CDCl 3 ): δ1.0-2.1 (b, 10H, cyclohexyl hydrogen), 2.2-2.9 (b, 1H, cyclohexyl carbonyl α-hydrogen), 4.38 (s, 2H, -COCH 2 N- ), 5.80 (dd, 1H, vinyl J 1-6 = 5.0 Hz, J 5-6 = 5.8 Hz), 6.30 (d, 1H, vinyl J 5-6 = 5.8), 9.15 (b, 1H, hydrogen of amine )
i. r. (KBr), cm-1:3230(s), 3100(m), 2900(m), 2830(w), 1680(s), 1610(s), 1395(m), 1310(w), 1270(w), 1170(m), 1070(w), 980(w), 920(w), 770(m)ir (KBr), cm -1 : 3230 (s), 3100 (m), 2900 (m), 2830 (w), 1680 (s), 1610 (s), 1395 (m), 1310 (w), 1270 (w), 1170 (m), 1070 (w), 980 (w), 920 (w), 770 (m)
[실시예 5]Example 5
1-페닐에칠-2-옥소-4-시클로헥실카보닐-1,2,3,4-테트라히드로피라진(Ⅰ; R1=C6H5CH2CH2, R2=C6H11)합성1-phenylethyl-2-oxo-4-cyclohexylcarbonyl-1,2,3,4-tetrahydropyrazine (I; R 1 = C 6 H 5 CH 2 CH 2 , R 2 = C 6 H 11 )synthesis
4-시클로헥실카보닐-1H-3,4-디히드로피라진-2-온(V;R2=C6H11) 1.96g(0.01몰)을 펜에틸브로마이드 2.41g(0.013몰), 디클로로메탄 20ml, 가성소다 1.40g, 무수 K2CO32.80g 함께 둥근 바닥 플라스크에 넣은 후 벤질트리(n-부틸)암모늄클로라이드 0.31g(0.1몰 당량) 넣고 4시간 40분동안 환류반응한 후-10℃로 냉각하여 고형물을 여과한다. 유기층에 100ml의 디클로로메탄을 첨가한 후 10ml의 포화 포테슘 카보네이트 수용액으로 두번 씻어 낸다. 유기층을 건조한후 농축한다. 농축액을 에칠아세테이트와 합하여 재결정하면 1.5g(48.1%)의 상기 화합물을 얻는다.1.96 g (0.01 mol) of 4-cyclohexylcarbonyl-1H-3,4-dihydropyrazin-2-one (V; R 2 = C 6 H 11 ) was dissolved in 2.41 g (0.013 mol) of phenethylbromide and dichloromethane. 20 ml, caustic soda 1.40 g, anhydrous K 2 CO 3 and 2.80 g were added to a round bottom flask, followed by 0.31 g (0.1 molar equivalent) of benzyl tri (n-butyl) ammonium chloride, followed by reflux for 4 hours and 40 minutes. Cool to to filter the solids. 100 ml of dichloromethane is added to the organic layer, and then washed twice with 10 ml of saturated potassium carbonate solution. The organic layer is dried and concentrated. The concentrate is combined with ethyl acetate to recrystallize to yield 1.5 g (48.1%) of the compound.
녹는점:131℃(에틸아세테이트)Melting Point: 131 ° C (Ethyl Acetate)
i. r. (KBr), cm-1:2900(m), 2830(w), 1650(s), 1630(sh), 1440(m), 1390(m), 1280(m), 980(w)ir (KBr), cm -1 : 2900 (m), 2830 (w), 1650 (s), 1630 (sh), 1440 (m), 1390 (m), 1280 (m), 980 (w)
[실시예 6]Example 6
1-벤질-2-옥소-4-아세틸-1,2,3,4-테트라히드로피라진(I;R1=C6H5CH2, R2=CH3)합성Synthesis of 1-benzyl-2-oxo-4-acetyl-1,2,3,4-tetrahydropyrazine (I; R 1 = C 6 H 5 CH 2 , R 2 = CH 3 )
4-아세틸-1H-3,4-디히드로피라진-2-온(V;R2=CH3) 1.27g(9.06×10-3몰), 무수 K2CO31.25g, 벤질클로라이드 1.38g(0.010몰)과 n-프로필알콜 25ml을 50ml 둥근 바닥플라스크에 넣고 6시 20간분동안 환류 반응시킨 뒤 냉각시킨다. 고형물을 여과하여 제거한 후 용매를 감압하여 날려 보내고 디클로로메탄 200ml을 넣고 50ml의 물로 두번 씻어 낸다. 유기층을 건조하고 에틸아세테이트와 헥산을 써서 재결정하면 1.53g(73.2%)의 상기 화합물을 얻는다.1.27 g (9.06 × 10 −3 mol) of 4-acetyl-1H-3,4-dihydropyrazin-2-one (V; R 2 = CH 3 ), 1.25 g of anhydrous K 2 CO 3 , 1.38 g of benzylchloride ( 0.010 mole) and 25 ml of n-propyl alcohol are placed in a 50 ml round bottom flask, and the mixture is refluxed at 6:20 for cooling. After filtering off the solids, the solvent was blown off under reduced pressure, 200 ml of dichloromethane was added and washed twice with 50 ml of water. Drying the organic layer and recrystallization with ethyl acetate and hexane yielded 1.53 g (73.2%) of the compound.
녹는점:80-82℃(에틸아세테이트)Melting Point: 80-82 ° C (Ethyl Acetate)
Hnmr(CDCl3):δ2.10(s, 3H, 아세틸), 4.32(s, 2H, -NCOCH2N-), 4.65(s, 2H, 벤질위치의 수소), 5.52(d, 1H, 비닐 J=6.0Hz), 6.05(d, 1H, 비닐J=6.0Hz), 7.22(s, 5H 페닐고리수소)Hnmr (CDCl 3 ): δ 2.10 (s, 3H, acetyl), 4.32 (s, 2H, -NCOCH 2 N-), 4.65 (s, 2H, hydrogen at benzyl), 5.52 (d, 1H, vinyl J = 6.0 Hz), 6.05 (d, 1H, vinyl J = 6.0 Hz), 7.22 (s, 5H phenylcyclic hydrogen)
i, r. (KBr), cm-1:3120(w), 1670(s), 1650(sh), 1460(m), 1440(m), 1420(s), 1400(m), 1350(m), 1300(m), 1170(w), 1090(w), 950(w), 900(w), 720(m), 700(w)i, r. (KBr), cm -1 : 3120 (w), 1670 (s), 1650 (sh), 1460 (m), 1440 (m), 1420 (s), 1400 (m), 1350 (m), 1300 ( m), 1170 (w), 1090 (w), 950 (w), 900 (w), 720 (m), 700 (w)
[실시예 7]Example 7
1-메틸-2-옥소-4-아세틸-1,2,3,4-테트라히드로피라진(Ⅰ;R1=R2=CH3)합성Synthesis of 1-methyl-2-oxo-4-acetyl-1,2,3,4-tetrahydropyrazine (I; R 1 = R 2 = CH 3 )
4-아세틸-1H-3,4-디히드로피라진-2-온(Ⅴ:R2=CH3) 1.32g(9.42×10-3)몰), 무수 K2CO31.69g, 디메틸포름아마이드 20ml을 50ml 둥근 바닥플라스크에 넣고 약 45시간후에 여과하여 고형물을 제거한다. 감압하여 디메틸포름아마이드를 제거한 후 에탄오롤 재결정하면 약 1.18g(81.3%)의 생성물을 얻는다.4-acetyl-1H-3,4-dihydropyrazin-2-one (V: R 2 = CH 3 ) 1.32 g (9.42 x 10 -3 ) mol), anhydrous K 2 CO 3 1.69 g, dimethylformamide 20 ml Into a 50ml round bottom flask and filtered after about 45 hours to remove the solids. Distillation under reduced pressure to remove dimethylformamide and recrystallization of ethanol yields about 1.18 g (81.3%) of product.
녹는점:141-144℃(에틸알콜)Melting Point: 141-144 ° C (Ethyl Alcohol)
Hnmr(D2O):δ2.10(s, 3H, 아세틸); 3.00(s, 3H, N-메틸); 4.20, 4.30(s, 2H, -N-CH2-CO-); 5.76, 5.80(d, 1H, 비닐수소 J=6.0Hz); 6.37, 6.51(d, 1H, 비닐수소 J=6.0Hz)Hnmr (D 2 O): δ 2.10 (s, 3H, acetyl); 3.00 (s, 3H, N-methyl); 4.20, 4.30 (s, 2H, -N-CH 2 -CO-); 5.76, 5.80 (d, 1H, vinyl hydrogen J = 6.0 Hz); 6.37, 6.51 (d, 1H, vinyl hydrogen J = 6.0 Hz)
i. r. (KBr):3060(w), 2925(w), 1660(s, broad), 1475(m), 1400(s), 1360(m), 1300(m), 1040(m), 930(w), 750(w)i. r. (KBr): 3060 (w), 2925 (w), 1660 (s, broad), 1475 (m), 1400 (s), 1360 (m), 1300 (m), 1040 (m), 930 (w) , 750 (w)
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019840005447A KR860001393B1 (en) | 1984-09-05 | 1984-09-05 | Process for the preparation of 1-alkyl-2-oxo-4-acyl-1,2,3,4-tetrahydropyrazines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019840005447A KR860001393B1 (en) | 1984-09-05 | 1984-09-05 | Process for the preparation of 1-alkyl-2-oxo-4-acyl-1,2,3,4-tetrahydropyrazines |
Publications (2)
Publication Number | Publication Date |
---|---|
KR860002480A KR860002480A (en) | 1986-04-26 |
KR860001393B1 true KR860001393B1 (en) | 1986-09-22 |
Family
ID=19235309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840005447A KR860001393B1 (en) | 1984-09-05 | 1984-09-05 | Process for the preparation of 1-alkyl-2-oxo-4-acyl-1,2,3,4-tetrahydropyrazines |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR860001393B1 (en) |
-
1984
- 1984-09-05 KR KR1019840005447A patent/KR860001393B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR860002480A (en) | 1986-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960003810B1 (en) | Process for producing optically active benzene-sulfonamide derivatives | |
KR0133051B1 (en) | Production of fluozetine and new intermediates | |
JP2003506425A (en) | Method for producing nitroxyalkyl ester of naproxen | |
US20090247755A1 (en) | Process for Preparing a Substituted Imidazopyridine Compound | |
EP0219256B1 (en) | N-alkylation of dihydrolysergic acid | |
KR920002295B1 (en) | Process for the preparation of pyrrolidone derivatives | |
GB1598668A (en) | Indolyloxymethyl-2-oxazolidinone derivatives and their use in the preparation of 1-amino-3-(indolyloxy)-2-propanols | |
US3960856A (en) | Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide | |
US4803270A (en) | Process of producing fluoroaniline derivatives | |
KR860001393B1 (en) | Process for the preparation of 1-alkyl-2-oxo-4-acyl-1,2,3,4-tetrahydropyrazines | |
US6337400B1 (en) | Process for the preparation of tetrahydroindolizines | |
US5461157A (en) | Process for preparing pyrrolidinylacetamide derivatives | |
EP0237899B1 (en) | Production of fluoroaniline derivatives | |
EP1611084A1 (en) | Process for the manufacture of n-alkoxalyl-alaninates | |
WO2016115962A1 (en) | Preparation method for nebivolol intermediate and preparation method for nebivolol | |
JPH0613477B2 (en) | 5-hydrazino-1H-pyrazole compound | |
EP0105763A1 (en) | Indole compounds, their preparation and pharmaceutical compositions comprising them | |
US6426417B1 (en) | Processes and intermediates useful to make antifolates | |
EP0839800A1 (en) | Process for preparing halogenoacetamide derivatives | |
EP0413832A1 (en) | Oxazolidinedione derivatives and production thereof | |
JPH0637449B2 (en) | Process for producing optically active atenolol and its intermediates | |
US4320056A (en) | Certain thia-diazatricyclo[3,3,3,08,11 ]tridecanes, and their preparation | |
US6355804B1 (en) | Process for producing piperidinecarboxylic acid amide derivatives | |
JP2641879B2 (en) | Preparation of optically active hydantoin derivatives | |
US4482711A (en) | Process for the preparation of N,N-dimethyl-10-[1-aza-[2,2,2]-bicyclo-3-octyl]-10H-2-phenothiazine sulphonamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19880212 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |